<?xml version="1.0" encoding="UTF-8"?>
<p>Isoniazid Preventive Therapy (IPT) is the recommended course of treatment to reduce the incidence of TB in PLWH. The challenge, according to the WHO, is ensuring continuation of care to reduce high rates of TB among PLWH who started ART [
 <xref rid="pone.0232841.ref004" ref-type="bibr">4</xref>]. Despite the adoption of a government program to provide IPT to tuberculosis child contacts and PLWH in 2011, by 2014 less than 10% of eligible individuals were receiving IPT [
 <xref rid="pone.0232841.ref005" ref-type="bibr">5</xref>]. Recent evidence points to the importance of self-selection of treatment delivery as a potential game-changing intervention to promote adherence of IPT [
 <xref rid="pone.0232841.ref006" ref-type="bibr">6</xref>], yet inadequate management of diagnosis and treatment are not having the desired success because of inadequate patient education, incomplete care coordination, and lack of healthcare communication [
 <xref rid="pone.0232841.ref007" ref-type="bibr">7</xref>; 
 <xref rid="pone.0232841.ref008" ref-type="bibr">8</xref>; 
 <xref rid="pone.0232841.ref009" ref-type="bibr">9</xref>].
</p>
